Breast carcinoma in situ is usually surgically removed, and some patients need to undergo radiotherapy, chemotherapy and endocrine therapy after surgery.
Breast carcinoma in situ is divided into ductal carcinoma in situ and lobular carcinoma in situ, which may develop into invasive cancer. Surgical excision is the mainstay of clinical practice, and most of the patients can be cured after total mastectomy or breast-conserving surgery to remove the lesion.
Most patients can be cured after total mastectomy or breast-conserving surgery to remove the lesion. Some patients are at high risk of recurrence and metastasis, and need to undergo a period of postoperative radiotherapy and chemotherapy; if they are receptor-positive carcinoma in situ, they need to take endocrine drugs for a certain period of time in order to be cured.
Patients with carcinoma in situ of breast are recommended to consult doctors in time and actively cooperate with them to prolong the survival period and improve the prognosis.